ÂÜÀòÂÒÂ×

Peter Ekhart has more than 23 years of experience in project management in multiple Life Science companies including Friesland Campina, TNO, Prosensa Therapeutics and ISA Therapeutics.

For Prosensa Therapeutics he managed two lead product development projects up to proof of concept resulting in the collaboration with GSK and recently a take over by Biomarin. At ISA, Ekhart realised the initiation of the first in man clinical study under GCP for the therapeutic vaccine against cervical cancer in 2013. In close collaboration with the UMCG and VU he organised and managed a clinical study for an oral hygiene product in Sjögren patients. For Aeon Astron he has managed the initiation of the BioCornea project resulting in a granted innovation credit loan of €3 M in 2012. Since 1990 Peter holds a master in (bio)chemistry, he completed a bioprocessing technology training at WUR in 1996 and he completed a MBA training in 2001.